Individuals with low vitamin D levels are more at risk of developing chronic inflammation compared to those with higher levels, new evidence has suggested.

Scientists from the University of South Australia have identified a connection between a lack of vitamin D and high inflammation.

According to the academics, chronic inflammation can trigger the development of cardiovascular disease, type 2 diabetes, obesity and autoimmune conditions.

During the study, the team of researchers used Mendelian randomisation to assess the vitamin D and C-reactive protein levels of more than 290,000 people.

First author Dr Ang Zhou said: “The findings suggest that boosting vitamin D in people with a deficiency may reduce chronic inflammation.

“Inflammation is your body’s way of protecting your tissues if you’ve been injured or have an infection.”

Dr Zhou added: “High levels of C-reactive protein are generated by the liver in response to inflammation, so when your body is experiencing chronic inflammation, it also shows higher levels of C-reactive protein.

“This study examined vitamin D and C-reactive proteins and found a one-way relationship between low levels of vitamin D and high levels of C-reactive protein, expressed as inflammation.

“Boosting vitamin D in people with deficiencies may reduce chronic inflammation, helping them avoid a number of related diseases.”

Fellow researcher Professor Elina Hyppönen said: “These results are important and provide an explanation for some of the controversies in reported associations with vitamin D.

“We have repeatedly seen evidence for health benefits for increasing vitamin D concentrations in individuals with very low levels, while for others, there appears to be little to no benefit.”

She concluded: “These findings highlight the importance of avoiding clinical vitamin D deficiency, and provide further evidence for the wide-ranging effects of hormonal vitamin D.”

The study has been published in the International Journal of Epidemiology.

Get our free newsletters

Stay up to date with the latest news, research and breakthroughs.